Pharmaceutical intermediates
Edoxaban tosylate monohydrate Intermediates
10 pharmaceutical intermediates for Edoxaban tosylate monohydrate. Indication: Pulmonary Embolism; Venous Thromboembolism; Stroke; Embolism; Venous Thrombosis.
About Edoxaban tosylate monohydrate
- Originator
- Daiichi Sankyo Co., Ltd
- Indication
- Pulmonary Embolism; Venous Thromboembolism; Stroke; Embolism; Venous Thrombosis
- Approved Date
- 01/08/2015
- DS/DP
- 04/18/2027
Available intermediates
10 intermediates currently listed for Edoxaban tosylate monohydrate. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| (S)-cyclohex-3-enecarboxylic acid | 5708-19-0 | / | / |
| (1S,4S,5S)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one | 139893-81-5 | / | / |
| 2-Bromo-5-methy1-4,5,6,7-tetrahydrothiazolo[5,4 -c]pyridine 4-methylbenzenesulfonate | 852291-42-0 | / | / |
| 2-Bromo-5-methy1-4,5,6,7-tetrahydrothiazolo[5,4 -c]pyridine | 143150-92-9 | / | / |
| N-(5-Chloropyridin-2-yl)oxalaMic acid ethyl ester | 349125-08-2 | / | / |
| tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate | 1210348-34-7 | / | / |
| tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate | 365998-36-3 | / | / |
| 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride | 720720-96-7 | / | / |
| 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride | 1243308-37-3 | / | / |
| Edoxaban tosylate monohydrate | 1229194-11-9 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →